Bluejay Diagnostics (BJDX) vs Profusa (PFSA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Bluejay Diagnostics is the larger company by market cap ($3.6 million vs $902,414), about 4.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BJDX | PFSA |
|---|---|---|
| Share price | $0.8156 | $1.49 |
| Market cap | $3.64M | $902.41K |
| 1-day change | +0.68% | -0.67% |
| P/E ratio (TTM) | — | 0.00 |
| EPS (TTM) | $-3.58 | $897.26 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $16.68 | $3,000.00 |
| 52-week low | $0.755 | $1.42 |
| Distance from 52-week high | -95.11% | -99.95% |
| Average volume | 3.81M | 2.73M |
| Shares outstanding | 4.47M | 605.65K |
| Employees | 6 | — |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Bluejay Diagnostics is about 4.0 times larger than Profusa by market value ($3.64M vs $902.41K).
About Bluejay Diagnostics
BJDX stock →Bluejay Diagnostics, Inc. operates as a medical diagnostics company.
Healthcare · Medical Devices · 6 employees
About Profusa
PFSA stock →Profusa, Inc., a digital health technology company, develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery.
Healthcare · Medical Devices
BJDX vs PFSA FAQ
Which is bigger, Bluejay Diagnostics or Profusa?
Bluejay Diagnostics (BJDX) is larger, with a market capitalization of $3.64M compared with $902.41K for Profusa (PFSA).
Are Bluejay Diagnostics and Profusa in the same industry?
Yes. Both are classified in the Medical Devices industry within the Healthcare sector.